Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Topic

Treatment (remove)
- Hepatitis C drugs (remove)
  - Epclusa (remove)
- Drug treatment strategies (2)
Emotional health (1)
Infections and cancers (1)

Filter by Infection

Filter by Resource Category

Search results

Current filters: Treatment, Hepatitis C drugs, Epclusa

6 search results

Epclusa (velpatasvir + sofosbuvir): 2020, CATIE
Fact sheet - Webpage
Sofosbuvir + velpatasvir – improvements in quality of life, energy and emotional and mental health: From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage
Sofosbuvir + velpatasvir – interactions with other medicines: From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage
Sofosbuvir + velpatasvir in HIV co-infection: From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage
Sofosbuvir + velpatasvir (Epclusa) + ribavirin for retreatment: From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage
The looming arrival of Epclusa – sofosbuvir + velpatasvir: From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.